Rockefeller University

New York, New York, United States


Purpose

to develop and evaluate novel antibody based molecules with enhanced in vivo activity for use in prevention of HIV-1 infection

Division

Global Health

Date

June 2015

Region Served

GLOBAL

Committed amount

$12,433,823

Grant topic

HIV

Duration (months)

88

Grantee location

New York, New York, United States

Related work

HIV

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.